Ftse Mib
36.267,63
1,25%
DAX
20.903,39
1,31%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
104.230,79
0,10%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ LENZ Therapeutics Inc (LENZ) LENZ Therapeutics Inc (LENZ) Notizie

LENZ Therapeutics Inc

LENZ
22,50
0,10 (0,45%)
18 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/11/202414:00GLOBELENZ Therapeutics to Participate in Upcoming Investor..
06/11/202413:00GLOBELENZ Therapeutics Reports Third Quarter 2024 Financial..
30/10/202413:00GLOBELENZ Therapeutics to Report Third Quarter Financial Results..
28/10/202402:00GLOBECORXEL and LENZ Therapeutics Announce Positive Topline Data..
21/10/202414:00GLOBELENZ Therapeutics Announces FDA Acceptance of New Drug..
30/9/202414:00GLOBELENZ Therapeutics Announces Presentations at Upcoming..
27/8/202422:01GLOBELENZ Therapeutics to Participate in Upcoming Investor..
14/8/202422:05GLOBELENZ Therapeutics Reports Second Quarter 2024 Financial..
12/8/202414:00GLOBELENZ Therapeutics Announces Submission of New Drug..
07/8/202422:01GLOBELENZ Therapeutics to Report Second Quarter 2024 Financial..
15/7/202414:00GLOBELENZ Therapeutics Announces $30 Million Investment from..
10/6/202414:00GLOBELENZ Therapeutics to Host Key Opinion Leader Event on June..
30/5/202414:00GLOBELENZ Therapeutics to Present at the Jefferies Global..
21/5/202414:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202422:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/5/202423:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:05EDGAR2Form 8-K - Current report
08/5/202422:01GLOBELENZ Therapeutics Reports First Quarter 2024 Financial..
01/5/202422:01GLOBELENZ Therapeutics to Report First Quarter Financial Results..
03/4/202413:00BWLENZ Therapeutics Announces Positive Topline Data from Phase..
02/4/202422:01BWLENZ Therapeutics to Host Investor Call to Discuss Topline..
Apertura: 22,64 Min: 22,34 Max: 23,4694
Chiusura: 22,40

La tua Cronologia

NASDAQ
LENZ
LENZ Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network